Celcuity (CELC) Total Liabilities (2016 - 2026)
Celcuity's (CELC) quarterly Total Liabilities came in at $366.0 million in Q4 2025, up 182.62% YoY from $129.5 million in Q4 2024, and up 1.94% on a QoQ basis from $359.0 million in Q3 2025.
Celcuity (CELC) Total Liabilities (2016 - 2026) Analysis & Trends
Celcuity (CELC) has 10 years of Total Liabilities data on file, last reported at $366.0 million in Q4 2025.
- Quarterly Total Liabilities rose 182.62% year-over-year to $366.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $366.0 million (up 182.62% YoY) and the FY2025 annual result came in at $366.0 million, up 182.62% from the prior year.
- Total Liabilities improved to $366.0 million in Q4 2025, from $359.0 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $366.0 million in Q4 2025 to a low of $1.2 million in Q1 2021.
- A 5-year average of $87.9 million and a median of $46.4 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2021 — Total Liabilities soared 1777.75% — and 2025, when it grew 20.16%.
- Tracing CELC's Total Liabilities over 5 years: stood at $17.2 million in 2021, then soared by 143.81% to $41.9 million in 2022, then grew by 22.72% to $51.5 million in 2023, then jumped by 151.71% to $129.5 million in 2024, then jumped by 182.62% to $366.0 million in 2025.
- The last three Total Liabilities figures came in at $366.0 million (Q4 2025), $359.0 million (Q3 2025), and $139.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - | 841.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 841.00 Mn |
| Dec 31, 2025 | 366.00 Mn |
| Sep 30, 2025 | 359.04 Mn |
| Jun 30, 2025 | 139.22 Mn |
| Mar 31, 2025 | 131.46 Mn |
| Dec 31, 2024 | 129.50 Mn |
| Sep 30, 2024 | 123.33 Mn |
| Jun 30, 2024 | 115.86 Mn |
| Mar 31, 2024 | 54.44 Mn |
| Dec 31, 2023 | 51.45 Mn |
| Sep 30, 2023 | 49.49 Mn |
| Jun 30, 2023 | 43.38 Mn |
| Mar 31, 2023 | 41.65 Mn |
| Dec 31, 2022 | 41.93 Mn |
| Sep 30, 2022 | 21.77 Mn |
| Jun 30, 2022 | 19.16 Mn |
| Mar 31, 2022 | 18.39 Mn |
| Dec 31, 2021 | 17.20 Mn |
| Sep 30, 2021 | 17.36 Mn |
| Jun 30, 2021 | 15.77 Mn |